PPP1CB and congenital heart disease: Ma et al. identified eight individuals with heterozygous, de novo variants in PPP1CB, presenting with intellectual disability, developmental delay, congenital heart disease, macrocephaly, short stature, and dysmorphic features (Ma et al., 2016).